Evaluation of efficacy of rigevidon in treating pubertal menorrhagia at Institute for Protection of Mother and Newborn
- Author:
Nguyen Ngoc Minh
- Publication Type:Journal Article
- Keywords:
menorrhagia, rigevidon
- MeSH:
Menorrhagia;
Ethinyl Estradiol-Norgestrel Combination;
Therapeutics
- From:Journal of Practical Medicine
2005;510(4):91-92
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Study on 80 symptomatic menorrhagia patients less than 18 years old treated at Institute for Protection of Mother and Newborn in the year 2000. Results: the rate of patients with irregular menstruation was highest (38.75%). 70% of patients lived in rural, so the rate of late hospital admission (>15 days) accounted for 73.75%. All patients suffered from anemia with 82.5% patients with moderate and severe anemia. Treatment with 2 tablets Rigevidon a day only one time in the evening until menorrhagia reduces, follows by 1 tablet a day for making artificial menstruation of 28 days, is effective in 96.25% patients. This finding showed that using Rigevidon for treating pubertal menorrhagia is simple, safe, and effective, no significant complication.
